Zobrazeno 1 - 4
of 4
pro vyhledávání: '"T. Martos Cardenas"'
Autor:
L.M. Masfarre Pinto, D. Pesque, F. Amorelli, N. Navarro Gorro, R. Bach Mora, J. Recuero, A. Gomez, D. Conde-Estévez, T. Martos Cardenas, M. Martinez Garcia, M. Castro-Henriques Pinto-Machado, N. Rodriguez de Dios, S. Segura, S. Servitja Tormo
Publikováno v:
ESMO Open. 8:101430
Autor:
F. Moreno Anton, M. Bellet-Ezquerra, L.M. Manso Sanchez, F. Henao Carrasco, A. Anton Torres, S. Morales, P. Tolosa Ortega, V.L. Obadia Gil, T. Sampedro, R. Andrés Conejero, L. Calvo-Martinez, E. Galve-Calvo, R. López, F. Ayala de la Pena, S. Lopez-Tarruella Cobo, B.A. Hernando Fernandez, L. Boronat Ruiz, T. Martos Cardenas, J.I. Chacon, N. Martinez Jañez
Publikováno v:
ESMO Open. 8:101422
Autor:
I. Tusquets Trias Bes, A. Rodriguez Arana, Joan Albanell, J.M. Corominas, L. Garrigos Cubells, T. Martos Cardenas, Maria Martinez-Garcia, I. Gonzalez Maeso, S. Servitja Tormo, M.D. Sabadell Mercadal
Publikováno v:
Annals of Oncology. 25:iv113
Background: Magnetic Resonance Imaging (MRI) is accepted as the best exploration to predict pathological response to neoadjuvant chemotherapy (NAC) in breast cancer. Our goal is to analyze the correlation between radiological complete response (rCR)
Autor:
A. Rodriguez Arana, M.D. Sabadell Mercadal, I. Tusquets Trias Bes, Maria Martinez-Garcia, T. Martos Cardenas, S. Servitja Tormo, Joan Albanell, I. Gonzalez Maeso, L. Garrigos Cubells, J.M. Corominas
Publikováno v:
Annals of Oncology. 25:iv114
Aim: Magnetic Resonance Imaging (MRI) is accepted as the best method to predict pathological response to neoadjuvant chemotherapy (NAC) in breast cancer patients, but some studies reported differences in the efficacy of MRI to detect pathological res